Chronic hydroxychloroquine therapy and COVID-19 outcomes: A retrospective case-control analysis

J Am Acad Dermatol. 2021 Jun;84(6):1769-1772. doi: 10.1016/j.jaad.2020.10.098. Epub 2021 Jan 10.

Authors

Lauren K Rangel¹, Payal Shah¹, Kristen Lo Sicco¹, Avrom S Caplan¹, Alisa Femia²

Affiliations

¹ Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.
² Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York. Electronic address: [email protected].

No abstract available

MeSH terms

Antiviral Agents / administration & dosage
Antiviral Agents / therapeutic use*
COVID-19 Drug Treatment*
Case-Control Studies
Drug Administration Schedule
Female
Humans
Hydroxychloroquine / administration & dosage
Hydroxychloroquine / therapeutic use*
Male
Middle Aged
Retrospective Studies
SARS-CoV-2
Treatment Outcome

Substances

Antiviral Agents
Hydroxychloroquine